Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,089 public trials 1,370 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Search for Predictors of Therapeutic Response in Ovarian Carcinoma

NCT01391351

Conditions
Adnexal Diseases, Carcinoma of the Ovary, Endocrine Gland Neoplasms, +17 more
Locations
  • Centre Eugène Marquis Rennes, Brittany Region, France
  • Centre François BACLESSE Caen, Calvados, France
  • Centre Réné Gauducheau Nantes, Loire-Atlantique, France
  • Centre Oscar LAMBRET Lille, Nord, France
View Trial Details
Completed

Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer

NCT00003546

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States
  • University of California San Diego Cancer Center La Jolla, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
View all 48 locations
View Trial Details
Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer

NCT00026130

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center Los Angeles, California, United States
  • Naval Medical Center - San Diego San Diego, California, United States
View all 77 locations
View Trial Details
Completed

OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer

NCT00382811

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +25 more
Locations
  • Arizona Clinical Research Center, Inc. Tuscon, Arizona, United States
  • Glendale Adventist Glendale, California, United States
  • Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 70 locations
View Trial Details
Completed

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

NCT01325558

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • University of Rochester Medical Center, James P. Wilmot Cancer Center Rochester, New York, United States
  • Carolinas Hematology-Oncology Associates Charlotte, North Carolina, United States
View Trial Details
Completed

Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer

NCT00004190

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
View all 19 locations
View Trial Details
Completed

Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas

NCT00012220

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Diego San Diego, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
View all 76 locations
View Trial Details
Completed

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

NCT02144051

Conditions
Adnexal Diseases, Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor, Breast Diseases, +32 more
Locations
  • Research Site Sarasota, Florida, United States
  • Research Site Nashville, Tennessee, United States
  • Research Site Milwaukee, Wisconsin, United States
  • Research Site London, United Kingdom
View Trial Details

Related conditions